Cargando…

MUG: A mutation overview of GPCR subfamily A17 receptors

G protein-coupled receptors (GPCRs) mediate several signaling pathways through a general mechanism that involves their activation, upholding a chain of events that lead to the release of molecules responsible for cytoplasmic action and further regulation. These physiological functions can be severel...

Descripción completa

Detalles Bibliográficos
Autores principales: Caniceiro, Ana B., Bueschbell, Beatriz, Barreto, Carlos A.V., Preto, António J., Moreira, Irina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822836/
https://www.ncbi.nlm.nih.gov/pubmed/36659920
http://dx.doi.org/10.1016/j.csbj.2022.12.031
_version_ 1784866033848287232
author Caniceiro, Ana B.
Bueschbell, Beatriz
Barreto, Carlos A.V.
Preto, António J.
Moreira, Irina S.
author_facet Caniceiro, Ana B.
Bueschbell, Beatriz
Barreto, Carlos A.V.
Preto, António J.
Moreira, Irina S.
author_sort Caniceiro, Ana B.
collection PubMed
description G protein-coupled receptors (GPCRs) mediate several signaling pathways through a general mechanism that involves their activation, upholding a chain of events that lead to the release of molecules responsible for cytoplasmic action and further regulation. These physiological functions can be severely altered by mutations in GPCR genes. GPCRs subfamily A17 (dopamine, serotonin, adrenergic and trace amine receptors) are directly related with neurodegenerative diseases, and as such it is crucial to explore known mutations on these systems and their impact in structure and function. A comprehensive and detailed computational framework - MUG (Mutations Understanding GPCRs) - was constructed, illustrating key reported mutations and their effect on receptors of the subfamily A17 of GPCRs. We explored the type of mutations occurring overall and in the different families of subfamily A17, as well their localization within the receptor and potential effects on receptor functionality. The mutated residues were further analyzed considering their pathogenicity. The results reveal a high diversity of mutations in the GPCR subfamily A17 structures, drawing attention to the considerable number of mutations in conserved residues and domains. Mutated residues were typically hydrophobic residues enriched at the ligand binding pocket and known activating microdomains, which may lead to disruption of receptor function. MUG as an interactive web application is available for the management and visualization of this dataset. We expect that this interactive database helps the exploration of GPCR mutations, their influence, and their familywise and receptor-specific effects, constituting the first step in elucidating their structures and molecules at the atomic level.
format Online
Article
Text
id pubmed-9822836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-98228362023-01-18 MUG: A mutation overview of GPCR subfamily A17 receptors Caniceiro, Ana B. Bueschbell, Beatriz Barreto, Carlos A.V. Preto, António J. Moreira, Irina S. Comput Struct Biotechnol J Research Article G protein-coupled receptors (GPCRs) mediate several signaling pathways through a general mechanism that involves their activation, upholding a chain of events that lead to the release of molecules responsible for cytoplasmic action and further regulation. These physiological functions can be severely altered by mutations in GPCR genes. GPCRs subfamily A17 (dopamine, serotonin, adrenergic and trace amine receptors) are directly related with neurodegenerative diseases, and as such it is crucial to explore known mutations on these systems and their impact in structure and function. A comprehensive and detailed computational framework - MUG (Mutations Understanding GPCRs) - was constructed, illustrating key reported mutations and their effect on receptors of the subfamily A17 of GPCRs. We explored the type of mutations occurring overall and in the different families of subfamily A17, as well their localization within the receptor and potential effects on receptor functionality. The mutated residues were further analyzed considering their pathogenicity. The results reveal a high diversity of mutations in the GPCR subfamily A17 structures, drawing attention to the considerable number of mutations in conserved residues and domains. Mutated residues were typically hydrophobic residues enriched at the ligand binding pocket and known activating microdomains, which may lead to disruption of receptor function. MUG as an interactive web application is available for the management and visualization of this dataset. We expect that this interactive database helps the exploration of GPCR mutations, their influence, and their familywise and receptor-specific effects, constituting the first step in elucidating their structures and molecules at the atomic level. Research Network of Computational and Structural Biotechnology 2022-12-21 /pmc/articles/PMC9822836/ /pubmed/36659920 http://dx.doi.org/10.1016/j.csbj.2022.12.031 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Caniceiro, Ana B.
Bueschbell, Beatriz
Barreto, Carlos A.V.
Preto, António J.
Moreira, Irina S.
MUG: A mutation overview of GPCR subfamily A17 receptors
title MUG: A mutation overview of GPCR subfamily A17 receptors
title_full MUG: A mutation overview of GPCR subfamily A17 receptors
title_fullStr MUG: A mutation overview of GPCR subfamily A17 receptors
title_full_unstemmed MUG: A mutation overview of GPCR subfamily A17 receptors
title_short MUG: A mutation overview of GPCR subfamily A17 receptors
title_sort mug: a mutation overview of gpcr subfamily a17 receptors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822836/
https://www.ncbi.nlm.nih.gov/pubmed/36659920
http://dx.doi.org/10.1016/j.csbj.2022.12.031
work_keys_str_mv AT caniceiroanab mugamutationoverviewofgpcrsubfamilya17receptors
AT bueschbellbeatriz mugamutationoverviewofgpcrsubfamilya17receptors
AT barretocarlosav mugamutationoverviewofgpcrsubfamilya17receptors
AT pretoantonioj mugamutationoverviewofgpcrsubfamilya17receptors
AT moreirairinas mugamutationoverviewofgpcrsubfamilya17receptors